Abstract
Background: Opioid-related deaths are a leading cause of pregnancy-associated mortality, and the prevalence of NOWS is increasing. Caregiving environments can reduce or eliminate the need for pharmacologic treatment of NOWS. However, insufficient parenting knowledge likely interferes with its optimal implementation. The primary objective of this study was to assess misinformation related to the peripartum transition and NOWS among women in treatment for opioid use disorder (OUD).
Methods: This is a secondary data analysis from an ongoing study to develop and test a patient education tool. A novel NOWS knowledge survey was developed based on clinical experience and literature consisting of 12 true/false questions. Pregnant (3rd trimester) and postpartum (< 7 days since delivery) women on medication for OUD (N = 22) completed this one-time, anonymous survey in a specialized clinic providing integrated perinatal and OUD care.
Results: The proportion of correct responses varied widely across question domains. Almost all women correctly identified NOWS signs/symptoms and nonpharmacologic NOWS treatments (100% skin-to-skin, 95% rooming in) except for breastfeeding (76% correct). Only 67% correctly stated that not all infants exposed to medication for OUD would need pharmacologic NOWS treatment, and 71% state that the infant would likely be discharged after the mother. Lastly, only 59% of women correctly reported that child welfare “will do what is best for me and my baby,” and 77% reported that the postpartum period is high risk for compromised recovery.
Conclusion: Despite receiving counseling from both obstetrics and addiction medicine providers, women on medication for OUD continue to have high levels of misinformation regarding expectations for the peripartum transition and care of the infant at risk of NOWS. Educational interventions tailored for the mother-infant dyad affected by OUD that can be easily implemented into clinical care are urgently needed, and patient-reported data should guide their development.
Methods: This is a secondary data analysis from an ongoing study to develop and test a patient education tool. A novel NOWS knowledge survey was developed based on clinical experience and literature consisting of 12 true/false questions. Pregnant (3rd trimester) and postpartum (< 7 days since delivery) women on medication for OUD (N = 22) completed this one-time, anonymous survey in a specialized clinic providing integrated perinatal and OUD care.
Results: The proportion of correct responses varied widely across question domains. Almost all women correctly identified NOWS signs/symptoms and nonpharmacologic NOWS treatments (100% skin-to-skin, 95% rooming in) except for breastfeeding (76% correct). Only 67% correctly stated that not all infants exposed to medication for OUD would need pharmacologic NOWS treatment, and 71% state that the infant would likely be discharged after the mother. Lastly, only 59% of women correctly reported that child welfare “will do what is best for me and my baby,” and 77% reported that the postpartum period is high risk for compromised recovery.
Conclusion: Despite receiving counseling from both obstetrics and addiction medicine providers, women on medication for OUD continue to have high levels of misinformation regarding expectations for the peripartum transition and care of the infant at risk of NOWS. Educational interventions tailored for the mother-infant dyad affected by OUD that can be easily implemented into clinical care are urgently needed, and patient-reported data should guide their development.
| Original language | English |
|---|---|
| Pages | 14 |
| Number of pages | 1 |
| Publication status | Published - 19 Jun 2020 |
| Event | 12th International Women’s and Children’s Health and Gender Group VIRTUAL Conference - 2020 Virtual InWomens Conference Duration: 19 Jun 2020 → 19 Jun 2020 Conference number: 12th https://gendercenter.rti.org/12th-international-womens-and-childrens-health-and-gender-group-virtual-conference |
Conference
| Conference | 12th International Women’s and Children’s Health and Gender Group VIRTUAL Conference |
|---|---|
| Abbreviated title | 2020 Virtual InWomens Conference |
| Period | 19/06/20 → 19/06/20 |
| Internet address |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Health Disparities
- Opiate Use
- Pregnant and Parenting Women
Fingerprint
Dive into the research topics of 'Neonatal Opioid Withdrawal Syndrome (NOWS) Knowledge Among Women in Treatment for Opioid Use Disorder'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver